The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global In Vitro Diagnostics (IVD) Products and Test Market Research Report 2024

Global In Vitro Diagnostics (IVD) Products and Test Market Research Report 2024

Publishing Date : Jan, 2024

License Type :
 

Report Code : 1884522

No of Pages : 103

Synopsis

The global In Vitro Diagnostics (IVD) Products and Test market was valued at US$ 81060 million in 2023 and is anticipated to reach US$ 126310 million by 2030, witnessing a CAGR of 6.5% during the forecast period 2024-2030.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs.

However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for In Vitro Diagnostics (IVD) Products and Test, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding In Vitro Diagnostics (IVD) Products and Test.

Report Scope

The In Vitro Diagnostics (IVD) Products and Test market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global In Vitro Diagnostics (IVD) Products and Test market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the In Vitro Diagnostics (IVD) Products and Test companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

By Company

  • Roche
  • Abbott
  • Danaher
  • Siemens Healthineers
  • Thermo Fisher Scientific
  • Sysmex
  • Biomerieux
  • Ortho Clinical Diagnostics
  • Becton Dickinson
  • Bio-Rad Laboratories
  • Hologic
  • Johnson and Johnson
  • Qiagen
  • Myriad Genetics
  • Wondfo
  • KHB
  • DAAN Gene
  • Leadman Biochemistry
  • Mindray
  • BioSino
  • LifeScan

Segment by Type

  • Immuno Diagnostic
  • Chemistry Diagnostic
  • Molecular Diagnostic
  • POCT
  • Others

Segment by Application

  • Hospital
  • Laboratory
  • Others

By Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Netherlands)
  • Asia-Pacific (China, Japan, South Korea, China Taiwan, Southeast Asia, India)
  • Latin America, Middle East & Africa (Latin America, Mexico, Brazil, Turkey)

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of In Vitro Diagnostics (IVD) Products and Test companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Index

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global In Vitro Diagnostics (IVD) Products and Test Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Immuno Diagnostic
1.2.3 Chemistry Diagnostic
1.2.4 Molecular Diagnostic
1.2.5 POCT
1.2.6 Others
1.3 Market by Application
1.3.1 Global In Vitro Diagnostics (IVD) Products and Test Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Laboratory
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global In Vitro Diagnostics (IVD) Products and Test Market Perspective (2019-2030)
2.2 In Vitro Diagnostics (IVD) Products and Test Growth Trends by Region
2.2.1 Global In Vitro Diagnostics (IVD) Products and Test Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 In Vitro Diagnostics (IVD) Products and Test Historic Market Size by Region (2019-2024)
2.2.3 In Vitro Diagnostics (IVD) Products and Test Forecasted Market Size by Region (2025-2030)
2.3 In Vitro Diagnostics (IVD) Products and Test Market Dynamics
2.3.1 In Vitro Diagnostics (IVD) Products and Test Industry Trends
2.3.2 In Vitro Diagnostics (IVD) Products and Test Market Drivers
2.3.3 In Vitro Diagnostics (IVD) Products and Test Market Challenges
2.3.4 In Vitro Diagnostics (IVD) Products and Test Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top In Vitro Diagnostics (IVD) Products and Test Players by Revenue
3.1.1 Global Top In Vitro Diagnostics (IVD) Products and Test Players by Revenue (2019-2024)
3.1.2 Global In Vitro Diagnostics (IVD) Products and Test Revenue Market Share by Players (2019-2024)
3.2 Global In Vitro Diagnostics (IVD) Products and Test Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by In Vitro Diagnostics (IVD) Products and Test Revenue
3.4 Global In Vitro Diagnostics (IVD) Products and Test Market Concentration Ratio
3.4.1 Global In Vitro Diagnostics (IVD) Products and Test Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by In Vitro Diagnostics (IVD) Products and Test Revenue in 2023
3.5 In Vitro Diagnostics (IVD) Products and Test Key Players Head office and Area Served
3.6 Key Players In Vitro Diagnostics (IVD) Products and Test Product Solution and Service
3.7 Date of Enter into In Vitro Diagnostics (IVD) Products and Test Market
3.8 Mergers & Acquisitions, Expansion Plans
4 In Vitro Diagnostics (IVD) Products and Test Breakdown Data by Type
4.1 Global In Vitro Diagnostics (IVD) Products and Test Historic Market Size by Type (2019-2024)
4.2 Global In Vitro Diagnostics (IVD) Products and Test Forecasted Market Size by Type (2025-2030)
5 In Vitro Diagnostics (IVD) Products and Test Breakdown Data by Application
5.1 Global In Vitro Diagnostics (IVD) Products and Test Historic Market Size by Application (2019-2024)
5.2 Global In Vitro Diagnostics (IVD) Products and Test Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America In Vitro Diagnostics (IVD) Products and Test Market Size (2019-2030)
6.2 North America In Vitro Diagnostics (IVD) Products and Test Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America In Vitro Diagnostics (IVD) Products and Test Market Size by Country (2019-2024)
6.4 North America In Vitro Diagnostics (IVD) Products and Test Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe In Vitro Diagnostics (IVD) Products and Test Market Size (2019-2030)
7.2 Europe In Vitro Diagnostics (IVD) Products and Test Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe In Vitro Diagnostics (IVD) Products and Test Market Size by Country (2019-2024)
7.4 Europe In Vitro Diagnostics (IVD) Products and Test Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific In Vitro Diagnostics (IVD) Products and Test Market Size (2019-2030)
8.2 Asia-Pacific In Vitro Diagnostics (IVD) Products and Test Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific In Vitro Diagnostics (IVD) Products and Test Market Size by Region (2019-2024)
8.4 Asia-Pacific In Vitro Diagnostics (IVD) Products and Test Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America In Vitro Diagnostics (IVD) Products and Test Market Size (2019-2030)
9.2 Latin America In Vitro Diagnostics (IVD) Products and Test Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America In Vitro Diagnostics (IVD) Products and Test Market Size by Country (2019-2024)
9.4 Latin America In Vitro Diagnostics (IVD) Products and Test Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa In Vitro Diagnostics (IVD) Products and Test Market Size (2019-2030)
10.2 Middle East & Africa In Vitro Diagnostics (IVD) Products and Test Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa In Vitro Diagnostics (IVD) Products and Test Market Size by Country (2019-2024)
10.4 Middle East & Africa In Vitro Diagnostics (IVD) Products and Test Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Detail
11.1.2 Roche Business Overview
11.1.3 Roche In Vitro Diagnostics (IVD) Products and Test Introduction
11.1.4 Roche Revenue in In Vitro Diagnostics (IVD) Products and Test Business (2019-2024)
11.1.5 Roche Recent Development
11.2 Abbott
11.2.1 Abbott Company Detail
11.2.2 Abbott Business Overview
11.2.3 Abbott In Vitro Diagnostics (IVD) Products and Test Introduction
11.2.4 Abbott Revenue in In Vitro Diagnostics (IVD) Products and Test Business (2019-2024)
11.2.5 Abbott Recent Development
11.3 Danaher
11.3.1 Danaher Company Detail
11.3.2 Danaher Business Overview
11.3.3 Danaher In Vitro Diagnostics (IVD) Products and Test Introduction
11.3.4 Danaher Revenue in In Vitro Diagnostics (IVD) Products and Test Business (2019-2024)
11.3.5 Danaher Recent Development
11.4 Siemens Healthineers
11.4.1 Siemens Healthineers Company Detail
11.4.2 Siemens Healthineers Business Overview
11.4.3 Siemens Healthineers In Vitro Diagnostics (IVD) Products and Test Introduction
11.4.4 Siemens Healthineers Revenue in In Vitro Diagnostics (IVD) Products and Test Business (2019-2024)
11.4.5 Siemens Healthineers Recent Development
11.5 Thermo Fisher Scientific
11.5.1 Thermo Fisher Scientific Company Detail
11.5.2 Thermo Fisher Scientific Business Overview
11.5.3 Thermo Fisher Scientific In Vitro Diagnostics (IVD) Products and Test Introduction
11.5.4 Thermo Fisher Scientific Revenue in In Vitro Diagnostics (IVD) Products and Test Business (2019-2024)
11.5.5 Thermo Fisher Scientific Recent Development
11.6 Sysmex
11.6.1 Sysmex Company Detail
11.6.2 Sysmex Business Overview
11.6.3 Sysmex In Vitro Diagnostics (IVD) Products and Test Introduction
11.6.4 Sysmex Revenue in In Vitro Diagnostics (IVD) Products and Test Business (2019-2024)
11.6.5 Sysmex Recent Development
11.7 Biomerieux
11.7.1 Biomerieux Company Detail
11.7.2 Biomerieux Business Overview
11.7.3 Biomerieux In Vitro Diagnostics (IVD) Products and Test Introduction
11.7.4 Biomerieux Revenue in In Vitro Diagnostics (IVD) Products and Test Business (2019-2024)
11.7.5 Biomerieux Recent Development
11.8 Ortho Clinical Diagnostics
11.8.1 Ortho Clinical Diagnostics Company Detail
11.8.2 Ortho Clinical Diagnostics Business Overview
11.8.3 Ortho Clinical Diagnostics In Vitro Diagnostics (IVD) Products and Test Introduction
11.8.4 Ortho Clinical Diagnostics Revenue in In Vitro Diagnostics (IVD) Products and Test Business (2019-2024)
11.8.5 Ortho Clinical Diagnostics Recent Development
11.9 Becton Dickinson
11.9.1 Becton Dickinson Company Detail
11.9.2 Becton Dickinson Business Overview
11.9.3 Becton Dickinson In Vitro Diagnostics (IVD) Products and Test Introduction
11.9.4 Becton Dickinson Revenue in In Vitro Diagnostics (IVD) Products and Test Business (2019-2024)
11.9.5 Becton Dickinson Recent Development
11.10 Bio-Rad Laboratories
11.10.1 Bio-Rad Laboratories Company Detail
11.10.2 Bio-Rad Laboratories Business Overview
11.10.3 Bio-Rad Laboratories In Vitro Diagnostics (IVD) Products and Test Introduction
11.10.4 Bio-Rad Laboratories Revenue in In Vitro Diagnostics (IVD) Products and Test Business (2019-2024)
11.10.5 Bio-Rad Laboratories Recent Development
11.11 Hologic
11.11.1 Hologic Company Detail
11.11.2 Hologic Business Overview
11.11.3 Hologic In Vitro Diagnostics (IVD) Products and Test Introduction
11.11.4 Hologic Revenue in In Vitro Diagnostics (IVD) Products and Test Business (2019-2024)
11.11.5 Hologic Recent Development
11.12 Johnson and Johnson
11.12.1 Johnson and Johnson Company Detail
11.12.2 Johnson and Johnson Business Overview
11.12.3 Johnson and Johnson In Vitro Diagnostics (IVD) Products and Test Introduction
11.12.4 Johnson and Johnson Revenue in In Vitro Diagnostics (IVD) Products and Test Business (2019-2024)
11.12.5 Johnson and Johnson Recent Development
11.13 Qiagen
11.13.1 Qiagen Company Detail
11.13.2 Qiagen Business Overview
11.13.3 Qiagen In Vitro Diagnostics (IVD) Products and Test Introduction
11.13.4 Qiagen Revenue in In Vitro Diagnostics (IVD) Products and Test Business (2019-2024)
11.13.5 Qiagen Recent Development
11.14 Myriad Genetics
11.14.1 Myriad Genetics Company Detail
11.14.2 Myriad Genetics Business Overview
11.14.3 Myriad Genetics In Vitro Diagnostics (IVD) Products and Test Introduction
11.14.4 Myriad Genetics Revenue in In Vitro Diagnostics (IVD) Products and Test Business (2019-2024)
11.14.5 Myriad Genetics Recent Development
11.15 Wondfo
11.15.1 Wondfo Company Detail
11.15.2 Wondfo Business Overview
11.15.3 Wondfo In Vitro Diagnostics (IVD) Products and Test Introduction
11.15.4 Wondfo Revenue in In Vitro Diagnostics (IVD) Products and Test Business (2019-2024)
11.15.5 Wondfo Recent Development
11.16 KHB
11.16.1 KHB Company Detail
11.16.2 KHB Business Overview
11.16.3 KHB In Vitro Diagnostics (IVD) Products and Test Introduction
11.16.4 KHB Revenue in In Vitro Diagnostics (IVD) Products and Test Business (2019-2024)
11.16.5 KHB Recent Development
11.17 DAAN Gene
11.17.1 DAAN Gene Company Detail
11.17.2 DAAN Gene Business Overview
11.17.3 DAAN Gene In Vitro Diagnostics (IVD) Products and Test Introduction
11.17.4 DAAN Gene Revenue in In Vitro Diagnostics (IVD) Products and Test Business (2019-2024)
11.17.5 DAAN Gene Recent Development
11.18 Leadman Biochemistry
11.18.1 Leadman Biochemistry Company Detail
11.18.2 Leadman Biochemistry Business Overview
11.18.3 Leadman Biochemistry In Vitro Diagnostics (IVD) Products and Test Introduction
11.18.4 Leadman Biochemistry Revenue in In Vitro Diagnostics (IVD) Products and Test Business (2019-2024)
11.18.5 Leadman Biochemistry Recent Development
11.19 Mindray
11.19.1 Mindray Company Detail
11.19.2 Mindray Business Overview
11.19.3 Mindray In Vitro Diagnostics (IVD) Products and Test Introduction
11.19.4 Mindray Revenue in In Vitro Diagnostics (IVD) Products and Test Business (2019-2024)
11.19.5 Mindray Recent Development
11.20 BioSino
11.20.1 BioSino Company Detail
11.20.2 BioSino Business Overview
11.20.3 BioSino In Vitro Diagnostics (IVD) Products and Test Introduction
11.20.4 BioSino Revenue in In Vitro Diagnostics (IVD) Products and Test Business (2019-2024)
11.20.5 BioSino Recent Development
11.21 LifeScan
11.21.1 LifeScan Company Detail
11.21.2 LifeScan Business Overview
11.21.3 LifeScan In Vitro Diagnostics (IVD) Products and Test Introduction
11.21.4 LifeScan Revenue in In Vitro Diagnostics (IVD) Products and Test Business (2019-2024)
11.21.5 LifeScan Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Published By : QY Research

Why ‘The Market Reports’